
New publication in Antiobiotics
The BCD Group is proud to share our latest publication in Antibiotics! Congratulations to our colleagues Bruno F. Gomes-Ribeiro and Mónica Echeverry-Rendón for this excellent achievement! Title: Inhibition of Biofilm
Image: Dr. Mónica Echeverry Rendón and Dr. Monsur Islam
Once upon a time, high above a vast Carbon Kingdom, lived a tiny Rapunzel. She was not a princess in a castle, but a cluster of L929 fibroblasts perched on the edge of a dark carbon tower. For a while, she remained there, surrounded by the safety of the place where she had first settled. But every day she looked beyond the great circular abyss below and wondered what might exist on the other side. The kingdom seemed enormous, unfamiliar, and perhaps a little dangerous. Still, Rapunzel was curious. One day, she gathered her courage and began to let down her golden hair, stretching it carefully across the carbon walls in search of somewhere new to hold on to.
Her journey had begun. Strand by strand, Rapunzel reached farther into the unknown, anchoring herself wherever she could and pulling her body slowly across the scaffold. Some paths were steep, others disappeared into the darkness, but she kept exploring. Her hair became bridges, ropes, and lifelines connecting her to the strange landscape around her. What started as a cautious first step soon became an adventure of attachment, spreading and discovery. Beneath the microscope, our tiny Rapunzel is not waiting to be rescued, she is building her own way out, turning an engineered carbon scaffold into a living kingdom and proving that even a single cell can be an explorer.
The image shows mouse fibroblasts (L929) cultured on a carbon scaffold. The cells display pronounced cytoskeletal extensions that follow and interact with the three-dimensional surface of the material, revealing how cellular adhesion and spreading are influenced by scaffold architecture. These projections reflect the dynamic way in which cells sense, anchor to, and explore their surrounding microenvironment, providing valuable information about cell-material interactions and the potential of engineered scaffolds to support cellular colonization and integration.
PI – Group Leader
Don’t forget to follow us on Linkedin to keep updated of all the relevant information from the BCD group!

The BCD Group is proud to share our latest publication in Antibiotics! Congratulations to our colleagues Bruno F. Gomes-Ribeiro and Mónica Echeverry-Rendón for this excellent achievement! Title: Inhibition of Biofilm

Throughout the month, our team has been actively involved in outreach, science communication, and innovation-driven activities. At Madrid es Ciencia, our researchers Alex Mascaraque León and Ángela García de la

The BCD Group is proud to share our latest publication in Biomaterials Advances! Congratulations to our colleagues Jesús Ordoño, Carlos Aguilar Vega, Guillermo Domínguez, Andrés Díaz Lantada, Jon Molina-Aldareguia, and

The BCD Group is proud to share our latest publication in Antibiotics! Congratulations to our colleagues Bruno F. Gomes-Ribeiro and Mónica Echeverry-Rendón for this excellent achievement! Title: Inhibition of Biofilm

Throughout the month, our team has been actively involved in outreach, science communication, and innovation-driven activities. At Madrid es Ciencia, our researchers Alex Mascaraque León and Ángela García de la

The BCD Group is proud to share our latest publication in Biomaterials Advances! Congratulations to our colleagues Jesús Ordoño, Carlos Aguilar Vega, Guillermo Domínguez, Andrés Díaz Lantada, Jon Molina-Aldareguia, and
Nafiseh Mollaei, Alireza Rezaei, Biaobiao Yang, Mónica Echeverry-Rendón, Jon M. Molina-Aldreguía, Federico Sket, Javier Llorca, Acta Materialia, 2026
Mirella Llamosí, Bruno F. Gomes-Ribeiro, Mónica Echeverry-Rendón, Jose Yuste, Julio Sempere, Mirian Domenech, Antibiotics, 2026
Jesús Ordoño, Carlos Aguilar-Vega, Natalia Téllez-Fouz, Guillermo Domínguez, Carmelo de-María, Andrés Díaz-Lantada, Jon Molina-Aldareguia, Mónica Echeverry-Rendón, Biomaterials Advances, 2026